These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 36649146)
41. Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study. Robson ME; Reiner AS; Brooks JD; Concannon PJ; John EM; Mellemkjaer L; Bernstein L; Malone KE; Knight JA; Lynch CF; Woods M; Liang X; Haile RW; Duggan DJ; Shore RE; Smith SA; Thomas DC; Stram DO; Bernstein JL; J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521362 [TBL] [Abstract][Full Text] [Related]
42. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores. Barnes DR; Silvestri V; Leslie G; McGuffog L; Dennis J; Yang X; Adlard J; Agnarsson BA; Ahmed M; Aittomäki K; Andrulis IL; Arason A; Arnold N; Auber B; Azzollini J; Balmaña J; Barkardottir RB; Barrowdale D; Barwell J; Belotti M; Benitez J; Berthet P; Boonen SE; Borg Å; Bozsik A; Brady AF; Brennan P; Brewer C; Brunet J; Bucalo A; Buys SS; Caldés T; Caligo MA; Campbell I; Cassingham H; Christensen LL; Cini G; Claes KBM; ; ; Cook J; Coppa A; Cortesi L; Damante G; Darder E; Davidson R; de la Hoya M; De Leeneer K; de Putter R; Del Valle J; Diez O; Ding YC; Domchek SM; Donaldson A; Eason J; Eeles R; Engel C; Evans DG; Feliubadaló L; Fostira F; Frone M; Frost D; Gallagher D; Gehrig A; Giraud S; Glendon G; Godwin AK; Goldgar DE; Greene MH; Gregory H; Gross E; Hahnen E; Hamann U; Hansen TVO; Hanson H; Hentschel J; Horvath J; ; ; Izatt L; Izquierdo A; James PA; Janavicius R; Jensen UB; Johannsson OT; John EM; Kramer G; Kroeldrup L; Kruse TA; Lautrup C; Lazaro C; Lesueur F; Lopez-Fernández A; Mai PL; Manoukian S; Matrai Z; Matricardi L; Maxwell KN; Mebirouk N; Meindl A; Montagna M; Monteiro AN; Morrison PJ; Muranen TA; Murray A; Nathanson KL; Neuhausen SL; Nevanlinna H; Nguyen-Dumont T; Niederacher D; Olah E; Olopade OI; Palli D; Parsons MT; Pedersen IS; Peissel B; Perez-Segura P; Peterlongo P; Petersen AH; Pinto P; Porteous ME; Pottinger C; Pujana MA; Radice P; Ramser J; Rantala J; Robson M; Rogers MT; Rønlund K; Rump A; Sánchez de Abajo AM; Shah PD; Sharif S; Side LE; Singer CF; Stadler Z; Steele L; Stoppa-Lyonnet D; Sutter C; Tan YY; Teixeira MR; Teulé A; Thull DL; Tischkowitz M; Toland AE; Tommasi S; Toss A; Trainer AH; Tripathi V; Valentini V; van Asperen CJ; Venturelli M; Viel A; Vijai J; Walker L; Wang-Gohrke S; Wappenschmidt B; Whaite A; Zanna I; Offit K; Thomassen M; Couch FJ; Schmutzler RK; Simard J; Easton DF; Chenevix-Trench G; Antoniou AC; Ottini L; J Natl Cancer Inst; 2022 Jan; 114(1):109-122. PubMed ID: 34320204 [TBL] [Abstract][Full Text] [Related]
43. Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases. Lakeman IMM; Rodríguez-Girondo MDM; Lee A; Celosse N; Braspenning ME; van Engelen K; van de Beek I; van der Hout AH; Gómez García EB; Mensenkamp AR; Ausems MGEM; Hooning MJ; Adank MA; Hollestelle A; Schmidt MK; van Asperen CJ; Devilee P J Med Genet; 2023 Apr; 60(4):327-336. PubMed ID: 36137616 [TBL] [Abstract][Full Text] [Related]
44. Women's responses and understanding of polygenic breast cancer risk information. Yanes T; Kaur R; Meiser B; Scheepers-Joynt M; McInerny S; Barlow-Stewart K; Antill Y; Salmon L; Smyth C; James PA; Young MA Fam Cancer; 2020 Oct; 19(4):297-306. PubMed ID: 32430685 [TBL] [Abstract][Full Text] [Related]
45. Genetic clinicians' confidence in BOADICEA comprehensive breast cancer risk estimates and counselees' psychosocial outcomes: A prospective study. Brédart A; De Pauw A; Tüchler A; Lakeman IMM; Anota A; Rhiem K; Schmutzler R; van Asperen CJ; Devilee P; Stoppa-Lyonnet D; Kop JL; Dolbeault S Clin Genet; 2022 Jul; 102(1):30-39. PubMed ID: 35508697 [TBL] [Abstract][Full Text] [Related]
46. Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry. Dite GS; MacInnis RJ; Bickerstaffe A; Dowty JG; Allman R; Apicella C; Milne RL; Tsimiklis H; Phillips KA; Giles GG; Terry MB; Southey MC; Hopper JL Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):359-65. PubMed ID: 26677205 [TBL] [Abstract][Full Text] [Related]
47. Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition. Hughes E; Wagner S; Pruss D; Bernhisel R; Probst B; Abkevich V; Simmons T; Hullinger B; Judkins T; Rosenthal E; Roa B; Domchek SM; Eng C; Garber J; Gary M; Klemp J; Mukherjee S; Offit K; Olopade OI; Vijai J; Weitzel JN; Whitworth P; Yehia L; Gordon O; Pederson H; Kurian A; Slavin TP; Gutin A; Lanchbury JS JCO Precis Oncol; 2022 Nov; 6():e2200084. PubMed ID: 36331239 [TBL] [Abstract][Full Text] [Related]
49. Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk. Dite GS; Spaeth E; Murphy NM; Allman R Prostate; 2023 Jul; 83(10):962-969. PubMed ID: 37062910 [TBL] [Abstract][Full Text] [Related]
50. Polygenic risk scores for prediction of breast cancer risk in Asian populations. Ho WK; Tai MC; Dennis J; Shu X; Li J; Ho PJ; Millwood IY; Lin K; Jee YH; Lee SH; Mavaddat N; Bolla MK; Wang Q; Michailidou K; Long J; Wijaya EA; Hassan T; Rahmat K; Tan VKM; Tan BKT; Tan SM; Tan EY; Lim SH; Gao YT; Zheng Y; Kang D; Choi JY; Han W; Lee HB; Kubo M; Okada Y; Namba S; ; Park SK; Kim SW; Shen CY; Wu PE; Park B; Muir KR; Lophatananon A; Wu AH; Tseng CC; Matsuo K; Ito H; Kwong A; Chan TL; John EM; Kurian AW; Iwasaki M; Yamaji T; Kweon SS; Aronson KJ; Murphy RA; Koh WP; Khor CC; Yuan JM; Dorajoo R; Walters RG; Chen Z; Li L; Lv J; Jung KJ; Kraft P; Pharoah PDB; Dunning AM; Simard J; Shu XO; Yip CH; Taib NAM; Antoniou AC; Zheng W; Hartman M; Easton DF; Teo SH Genet Med; 2022 Mar; 24(3):586-600. PubMed ID: 34906514 [TBL] [Abstract][Full Text] [Related]
51. Breast cancer polygenic risk scores derived in White European populations are not calibrated for women of Ashkenazi Jewish descent. Roberts E; van Veen EM; Byers H; Barnett-Griness O; Gronich N; Lejbkowicz F; Pinchev M; Smith MJ; Howell A; Newman WG; Woodward ER; Harkness EF; Brentnall AR; Cuzick J; Rennert G; Howell SJ; Evans DG Genet Med; 2023 Sep; 25(9):100846. PubMed ID: 37061873 [TBL] [Abstract][Full Text] [Related]
52. The role of polygenic risk and susceptibility genes in breast cancer over the course of life. Mars N; Widén E; Kerminen S; Meretoja T; Pirinen M; Della Briotta Parolo P; Palta P; ; Palotie A; Kaprio J; Joensuu H; Daly M; Ripatti S Nat Commun; 2020 Dec; 11(1):6383. PubMed ID: 33318493 [TBL] [Abstract][Full Text] [Related]
54. Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women. Hou C; Xu B; Hao Y; Yang D; Song H; Li J BMC Cancer; 2022 Apr; 22(1):374. PubMed ID: 35395775 [TBL] [Abstract][Full Text] [Related]
55. Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes. Gallagher S; Hughes E; Wagner S; Tshiaba P; Rosenthal E; Roa BB; Kurian AW; Domchek SM; Garber J; Lancaster J; Weitzel JN; Gutin A; Lanchbury JS; Robson M JAMA Netw Open; 2020 Jul; 3(7):e208501. PubMed ID: 32609350 [TBL] [Abstract][Full Text] [Related]
56. Validating the IBIS and BOADICEA Models for Predicting Breast Cancer Risk in the Iranian Population. Ghoncheh M; Ziaee F; Karami M; Poorolajal J Clin Breast Cancer; 2017 Jun; 17(3):e113-e118. PubMed ID: 28216418 [TBL] [Abstract][Full Text] [Related]
57. Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer. Baliakas P; Munters AR; Kämpe A; Tesi B; Bondeson ML; Ladenvall C; Eriksson D J Med Genet; 2024 Jan; 61(2):150-154. PubMed ID: 37580114 [TBL] [Abstract][Full Text] [Related]
58. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. Dai J; Lv J; Zhu M; Wang Y; Qin N; Ma H; He YQ; Zhang R; Tan W; Fan J; Wang T; Zheng H; Sun Q; Wang L; Huang M; Ge Z; Yu C; Guo Y; Wang TM; Wang J; Xu L; Wu W; Chen L; Bian Z; Walters R; Millwood IY; Li XZ; Wang X; Hung RJ; Christiani DC; Chen H; Wang M; Wang C; Jiang Y; Chen K; Chen Z; Jin G; Wu T; Lin D; Hu Z; Amos CI; Wu C; Wei Q; Jia WH; Li L; Shen H Lancet Respir Med; 2019 Oct; 7(10):881-891. PubMed ID: 31326317 [TBL] [Abstract][Full Text] [Related]
59. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families. Antoniou AC; Durocher F; Smith P; Simard J; Easton DF; Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652 [TBL] [Abstract][Full Text] [Related]
60. Validation of a genetic risk score for Arkansas women of color. Starlard-Davenport A; Allman R; Dite GS; Hopper JL; Spaeth Tuff E; Macleod S; Kadlubar S; Preston M; Henry-Tillman R PLoS One; 2018; 13(10):e0204834. PubMed ID: 30281645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]